Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma

Journal of Clinical Oncology

Volumn 16, Issue 12, 1998, Pages 3803-3809

  Khouri, Issa F ^a   Romaguera, Jorge ^a   Kantarjian, Hagop ^a   Palmer, J Lynn ^a   Pugh, William C ^a   Korbling, Martin ^a   Hagemeister, Fredrick ^a   Samuels, Barry ^a   Rodriguez, Alma ^a   Giralt, Sergio ^a   Younes, Anas ^a   Przepiorka, Donna ^a   Claxton, David ^a   Cabanillas, Fernando ^a   Champlin, Richard ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0032422078     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.12.3803     Document Type: Article

References (27)

1. Banks PM, Chan J, Cleary ML, et al: Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637-640, 1992
2. Zucca E, Stein H, Coffier B: European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507-511, 1994
3. Berard CW: Reticuloendothelial system: An overview of neoplasia, in Rebuck JW, Berard C, Abell MR (eds): International Academy of Pathology Monograph (vol 16). Baltimore, MD, Williams and Wilkins, 1975, pp 301-317
4. Weisenburger DD, Nathwani BN, Diamond LW: Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases. Cancer 48:1415-1425, 1981
5. Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429-1438, 1982
6. Swerdlow SH, Habeshaw JA, Murray LJ, et al: Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity: A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol 113:181-197, 1983
7. Shivdasani RA, Hess JL, Skarin AT, et al: Intermediate lymphocytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 11:802-811, 1993
8. Pittaluga S, Bijnens L, Teodorovic I, et al: Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the revised European-American classification of lymphoid neoplasms: A comparison with the working formulation. Blood 87:4358-4367, 1996
9. Weisenburger DD, Armitage JO: Mantle cell lymphoma - An entity comes of age. Blood 87:4483-4494, 1996
10. Majlis A, Pugh W, Rodriguez M, et al: Mantle cell lymphoma: Correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 15:1664-1671, 1997
11. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
12. Haioun C, Lepage E, Gisselbrecht C, et al: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH 87-2. J Clin Oncol 15:1131-1137, 1997
13. Bowman WP, Shuster JJ, Cook B, et al: Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study. J Clin Oncol 14:1252-1261, 1996
14. Kantarjian H, O'Brien S, Beran M, et al: Update of the Hyper-CVAD program in newly-diagnosed adult acute lymphoblastic leukemia. Blood 86: 173a, 1995 (suppl 1, abstr)
15. Carbone PP, Kaplan HS, Musshoff K, et al: Report on the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
16. Rodriguez J, Cabanillas F, McLaughlin P, et al: A proposal for a simple staging system for intermediate-grade lymphoma and immunoblastic lymphoma based on the tumor score. Ann Oncol 3:711-717, 1992
17. Korbling M, Przepiorka D, Huh YO, et al: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659-1665, 1995
18. Law P, Ishizawa L, Van De Yen C, et al: Immunomagnetic positive selection and colony culture of CD34+ cells from blood. J Hematother 2:247-250, 1993
19. Khouri I, Keating M, Vriesendorp H, et al: Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J Clin Oncol 12:748-758, 1994
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Duggan MJ, Weisenburger DD, Ye YL, et al: Mantle zone lymphoma. A clinicopathologic study of 22 cases. Cancer 66:522-529, 1990
22. Bookman MA, Lardelli P, Jaffe ES, et al: Lymphocytic lymphoma of intermediate differentiation: Morphologic, immunophenotypic, and prognostic factors. J Natl Cancer Inst 82:742-748, 1990
23. Norton AJ, Mathews J, Pappa V, et al: Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249-256, 1995
24. Meusers P, Engelhard M, Bartels H, et al: Multicentre randomized therapeutic trial for advanced centrocytic lymphoma. Anthracy-cline does not improve prognosis. Hematol Oncol 7:365-380, 1989
25. Freedman AS, Neuberg D, Gribben JG, et al: High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission. J Clin Oncol 16: 13-18, 1998
26. Segal GH, Masih AS, Fox AC, et al: CDS-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogenous immunophenotype and are associated with an overall poor prognosis. Blood 85:1570-1579, 1995
27. van Besien KW, Khouri IF, Giralt SA, et al: Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: The case for aggressive management. J Clin Oncol 13:1096-1102, 1995